Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 26, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the Company's Ordinary Shares and American Depositary Receipts (ADRs).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transactions executed on March 22, 2007, by the GlaxoSmithKline Employee Trust ("GSK Trust") on behalf of employee plan participants:
- Sale of Shares: The GSK Trust sold 10,923 Ordinary Shares at a price of GBP 14.08 per share for the GlaxoSmithKline Performance Share Plan.
- Transfers to Participants: The GSK Trust transferred 40,892 Ordinary Shares to participants in the GlaxoSmithKline Performance Share Plan.
- Transfers to Option Plan: The GSK Trust transferred 21,025 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
Three directors (Dr J P Garnier, Dr M M Slaoui, and Mr J S Heslop) are noted as having an interest in the shares held within the GSK Trust in the same capacity as other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the aforementioned share transactions.
Key Facts for Investor Verification
- Verify the total number of shares sold versus transferred to ensure accurate tracking of the GSK Trust's holdings.
- Confirm the transaction price of GBP 14.08 against the market price on March 22, 2007.
- Note that the transactions were advised to the Company on March 23, 2007, and reported on March 26, 2007.
- Understand that the GSK Trust is a discretionary trust for current and former employees, not a direct holding by the named directors.